PRKACA antibody (AA 1-120)

Catalog No. ABIN519175

This Mouse Monoclonal antibody specifically detects PRKACA in WB, ELISA and PLA. It exhibits reactivity toward Human.

Quick Overview for PRKACA antibody (AA 1-120) (ABIN519175)

Target: PRKACA (Protein Kinase A, alpha (PRKACA))

Reactivity: Human

Host: Mouse

Clonality: Monoclonal

Conjugate: This PRKACA antibody is un-conjugated

Application: Western Blotting (WB), ELISA, Proximity Ligation Assay (PLA)

Clone: 1D7

Product Details anti-PRKACA Antibody

Binding Specificity: AA 1-120

Purpose: Mouse monoclonal antibody raised against a partial recombinant PRKACA.

Sequence: MGNAAAAKKG SEQESVKEFL AKAKEDFLKK WESPAQNTAH LDQFERIKTL GTGSFGRVML VKHKETGNHY AMKILDKQKV VKLKQIEHTL NEKRILQAVN FPFLVKLEFS FKDNSNLYMV

Cross-Reactivity: Human

Characteristics: Antibody Reactive Against Recombinant Protein.

Immunogen: PRKACA (AAH39846, 1 a.a. ~ 120 a.a) partial recombinant protein with GST tag. MW of the GST tag alone is 26 KDa.

Isotype: IgG1

Application Details

Application Notes: Optimal working dilution should be determined by the investigator.

Restrictions: For Research Use only

Handling

Buffer: In 1x PBS, pH 7.4

Handling Advice: Aliquot to avoid repeated freezing and thawing.

Storage: -20 °C

Storage Comment: Store at -20°C or lower. Aliquot to avoid repeated freezing and thawing.

Target Details for PRKACA

Target: PRKACA (Protein Kinase A, alpha (PRKACA))

Alternative Name: PRKACA

Background: Full Gene Name: protein kinase, cAMP-dependent, catalytic, alpha
Synonyms: MGC102831,MGC48865,PKACA

Gene ID: 5566

Pathways: NF-kappaB Signaling, Hedgehog Signaling, EGFR Signaling Pathway, Neurotrophin Signaling Pathway, Thyroid Hormone Synthesis, Carbohydrate Homeostasis, Myometrial Relaxation and Contraction, M Phase, G-protein mediated Events, Signaling Events mediated by VEGFR1 and VEGFR2, Interaction of EGFR with phospholipase C-gamma, Thromboxane A2 Receptor Signaling, VEGFR1 Specific Signals, Lipid Metabolism, SARS-CoV-2 Protein Interactome, The Global Phosphorylation Landscape of SARS-CoV-2 Infection